<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ateroskleroz</journal-id><journal-title-group><journal-title xml:lang="ru">Атеросклероз</journal-title><trans-title-group xml:lang="en"><trans-title>Ateroscleroz</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-256X</issn><issn pub-type="epub">2949-3633</issn><publisher><publisher-name>НИИТПМ-филиал ИЦиГ СО РАН</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.52727/2078-256X-2026-22-2-198-209</article-id><article-id custom-type="elpub" pub-id-type="custom">ateroskleroz-1195</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Индекс триглицериды – глюкоза (TyG) и его производные у женщин репродуктивного возраста с разными метаболическими фенотипами</article-title><trans-title-group xml:lang="en"><trans-title>Triglyceride – glucose index and its derivatives in women of reproductive age with different metabolic phenotypes</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1645-5523</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Алфёрова</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Alferova</surname><given-names>V. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Алфёрова Влада Игоревна, канд. мед. наук</p><p>630089, г. Новосибирск, ул. Бориса Богаткова,175/1</p></bio><bio xml:lang="en"><p>Vlada I. Alferova, candidate of medical sciences</p><p>175/1, Boris Bogatkov st., Novosibirsk, 630089</p></bio><email xlink:type="simple">lady.alfyorova2009@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4716-876X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мустафина</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Mustafina</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мустафина Светлана Владимировна, д-р мед. наук</p><p>630089, г. Новосибирск, ул. Бориса Богаткова,175/1</p></bio><bio xml:lang="en"><p>Svetlana V. Mustafina, doctor of medical sciences</p><p>175/1, Boris Bogatkov st., Novosibirsk, 630089</p></bio><email xlink:type="simple">svetlana3548@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4095-0169</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рымар</surname><given-names>О. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Rymar</surname><given-names>O. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Рымар Оксана Дмитриевна, д-р мед. наук</p><p>630089, г. Новосибирск, ул. Бориса Богаткова,175/1</p></bio><bio xml:lang="en"><p>Oksana D. Rymar, doctor of medical sciences</p><p>175/1, Boris Bogatkov st., Novosibirsk, 630089</p></bio><email xlink:type="simple">orymar23@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9270-9188</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Щербакова</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shcherbakova</surname><given-names>L. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Щербакова Лилия Валерьевна</p><p>630089, г. Новосибирск, ул. Бориса Богаткова,175/1</p></bio><bio xml:lang="en"><p>Lilia V. Shcherbakova</p><p>175/1, Boris Bogatkov st., Novosibirsk, 630089</p></bio><email xlink:type="simple">9584792@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2470-2133</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Денисова</surname><given-names>Д. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Denisova</surname><given-names>D. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Денисова Диана Вахтанговна, д-р мед. наук</p><p>630089, г. Новосибирск, ул. Бориса Богаткова,175/1</p></bio><bio xml:lang="en"><p>Diana V. Denisova, doctor of medical sciences</p><p>175/1, Boris Bogatkov st., Novosibirsk, 630089</p></bio><email xlink:type="simple">denisovadiana@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научно-исследовательский институт терапии и профилактической медицины – филиал Федерального государственного бюджетного научного учреждения «Федеральный исследовательский центр Институт цитологии и генетики Сибирского отделения Российской академии наук»</institution></aff><aff xml:lang="en"><institution>Research Institute of Internal and Preventive Medicine – Branch of the Institute of Cytology and Genetics, Siberian Branch of the Russia Academy of Sciences</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>30</day><month>06</month><year>2026</year></pub-date><volume>22</volume><issue>2</issue><fpage>198</fpage><lpage>209</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Алфёрова В.И., Мустафина С.В., Рымар О.Д., Щербакова Л.В., Денисова Д.В., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Алфёрова В.И., Мустафина С.В., Рымар О.Д., Щербакова Л.В., Денисова Д.В.</copyright-holder><copyright-holder xml:lang="en">Alferova V.I., Mustafina S.V., Rymar O.D., Shcherbakova L.V., Denisova D.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://ateroskleroz.elpub.ru/jour/article/view/1195">https://ateroskleroz.elpub.ru/jour/article/view/1195</self-uri><abstract><p>В последние годы активно изучается теория метаболического фенотипирования, в основе которой лежит выделение метаболически здорового и нездорового фенотипов (МЗФ, МНЗФ) у лиц с разным индексом массы тела (ИМТ). По данным литературы, в основе формирования МНЗФ лежит инсулинорезистентность (ИР). Одним из наиболее доступных в практической деятельности инструментов для оценки ИР является индекс триглицериды–глюкоза TyG и его производные. Однако до сих пор недостаточно информации об особенностях показателей ИР у лиц с различными метаболическими фенотипами. Цель – изучить показатели индексов инсулинорезистентности, основанных на индексе TyG, в выборке женщин 25–44 лет г. Новосибирска. Материал и методы. Обследована репрезентативная выборка женщин в возрасте 25–44 лет, проживающих в г. Новосибирске, в итоговую выборку вошли показатели 651 женщины. Дизайн исследования: одномоментное популяционное исследование. Проведено антропометрическое и лабораторное обследование. В качестве дефиниций метаболически нездорового фенотипа учитывали критерии метаболического синдрома IDF, 2005. Статистическую обработку результатов проводили в программе SPSS for Windows. Результаты. Молодые женщины с МНЗФ имели достоверно более высокие индексы TyG, TyG-ИМТ, TyG-ОТ, TyG-ОТ/рост, чем лица с МЗФ как во всей выборке, так и при разделении на группы по ИМТ (p &lt; 0,05). При повышении ИМТ от нормальной массы тела к ожирению выявлено значимое повышение TyG-ИМТ, TyG-ОТ, TyG-ОТ/рост (p &lt; 0,0001), но не индекса TyG. При оценке способности изучаемых индексов распознавать наличие МНЗФ для всех индексов получены модели хорошего (TyG) и отличного качества (TyG-ИМТ, TyG-ОТ, TyG-ОТ/рост). Наиболее высокое качество модели получено для индекса TyG-ОТ (AUC = 0,930, p &lt; 0,0001), пороговое значение для распознавания МНЗФ – 368,3 (Se = 93,8 %, Sp = 79,1 %). Заключение. Выявлены более высокие индексы инсулинорезистентности, основанные на TyG, у женщин с МНЗФ по сравнению с МЗФ при любом значении индекса массы тела. Индекс TyG- ОТ показал наибольшую способность к распознаванию МНЗФ у молодых женщин.</p></abstract><trans-abstract xml:lang="en"><p>In recent years, the theory of metabolic phenotyping has been actively studied, which is based on the identification of metabolically healthy (MHP) and unhealthy phenotypes (MUHP) people with different body mass index (BMI). According to the literature, the basis for the formation of MUHP is insulin resistance (IR). One of the most practically accessible tools for assessing IR is the TyG index and its derivatives. However, there is still insufficient information about the features of IR indicators in individuals with different metabolic phenotypes. Aim is to study the indices of insulin resistance based on the TyG index in a sample of women aged 25–44 in Novosibirsk. Material and methods. A representative sample of women aged 25–44 years living in Novosibirsk was examined, the final sample included 651 women. Study design: a single-stage population-based study. An anthropometric and laboratory examination was performed. The criteria of metabolic syndrome IDF, 2005, were considered as definitions of a metabolically unhealthy phenotype. Statistical processing of the results was carried out in the SPSS for Windows program. Results. Young women with MUHP had significantly higher TyG, TyG-BMI, TyG-WC, TyG-WC/height indices than those with MHP both in the entire sample and when divided into groups by BMI (p &lt; 0.05). With an increase in BMI from normal body weight to obesity, a significant increase in TyG-BMI, TyGWC, TyG-WC/height (p &lt; 0.0001) was revealed, but not the TyG index. When evaluating the ability of the studied indices to recognize the presence of MUHP, models of good (TyG) and excellent quality (TyG-BMI, TyG-WC, TyG-WC/height) were obtained for all indices. The highest quality of the model was obtained for the TyG-WC index (AUC = 0.930, p &lt; 0.0001), the cut-off value for MUHP recognition was 368.3 (Se = 93.8 %, Sp = 79.1 %). Conclusions. Higher TyG-based insulin resistance indices were found in women with MUHP compared with MHP at any body mass index value, the TyG-WC index showed the greatest ability to recognize MUHP in young women.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ожирение</kwd><kwd>метаболически нездоровый фенотип</kwd><kwd>метаболический синдром</kwd><kwd>индекс TyG</kwd></kwd-group><kwd-group xml:lang="en"><kwd>obesity</kwd><kwd>metabolically unhealthy phenotype</kwd><kwd>metabolic syndrome</kwd><kwd>young women</kwd><kwd>TyG index</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Статья подготовлена в рамках бюджетной темы «Совершенствование методов диагностики метаболических нарушений у пациентов с неиммунными формами сахарного диабета, проживающих в Сибири, и оптимизация лекарственной терапии, улучшающей прогноз», 2026–2028 гг. (FWNR-2026-0035).</funding-statement><funding-statement xml:lang="en">This article was prepared within the framework of the budget theme «Improving diagnostic methods for metabolic disorders in patients with non-immune forms of diabetes mellitus living in Siberia and optimizing drug therapy to improve prognosis» 2026–2028 (FWNR-2026-0035).</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Алфёрова В.И., Мустафина С.В. Адипоцитокины сквозь призму метаболических фенотипов человека. Доктор. Ру. 2023; 22 (4): 18–23.</mixed-citation><mixed-citation xml:lang="en">Alferova V.I., Mustafina S.V. Adipocytokines through the prism of human metabolic phenotypes. Doctor.Ru. 2023; 22 (4): 18–23 (in Russ.). doi: 10.31550/1727-2378-2023-22-4-18-23</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Kishore B.K. Reverse epidemiology of obesity paradox: Fact or fiction? Physiol. Rep. 2024 Nov; 12 (21): e70107. doi: 10.14814/phy2.70107</mixed-citation><mixed-citation xml:lang="en">Kishore B.K. Reverse epidemiology of obesity paradox: Fact or fiction? Physiol. Rep. 2024 Nov; 12 (21): e70107. doi: 10.14814/phy2.70107</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Elías-López D., Vargas-Vázquez A., Mehta R., et al. Metabolic Syndrome Study Group. Natural course of metabolically healthy phenotype and risk of developing cardiometabolic diseases: a three years follow-up study. BMC Endocr. Disord. 2021 Apr 28; 21 (1): 85. doi: 10.1186/s12902-021-00754-1</mixed-citation><mixed-citation xml:lang="en">Elías-López D., Vargas-Vázquez A., Mehta R., et al. Metabolic Syndrome Study Group. Natural course of metabolically healthy phenotype and risk of developing cardiometabolic diseases: a three years follow-up study. BMC Endocr. Disord. 2021 Apr 28; 21 (1): 85. doi: 10.1186/s12902-021-00754-1</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Janus A., Szahidewicz-Krupska E., Mazur G., Doroszko A. Insulin Resistance and Endothelial Dysfunction Constitute a Common Therapeutic Target in Cardiometabolic Disorders. Mediators Inflamm. 2016; 2016: 3634948. doi: 10.1155/2016/3634948.</mixed-citation><mixed-citation xml:lang="en">Janus A., Szahidewicz-Krupska E., Mazur G., Doroszko A. Insulin Resistance and Endothelial Dysfunction Constitute a Common Therapeutic Target in Cardiometabolic Disorders. Mediators Inflamm. 2016; 2016: 3634948. doi: 10.1155/2016/3634948.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">DeFronzo R.A., Tobin J.D., Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 1979 Sep; 237 (3): E214–223. doi: 10.1152/ajpendo.1979.237.3.E214</mixed-citation><mixed-citation xml:lang="en">DeFronzo R.A., Tobin J.D., Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 1979 Sep; 237 (3): E214–223. doi: 10.1152/ajpendo.1979.237.3.E214</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Bonora E., Targher G., Alberiche M., Bonadonna R.C., Saggiani F., Zenere M.B., Monauni T., Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000 Jan; 23 (1): 57–63. doi: 10.2337/diacare.23.1.57</mixed-citation><mixed-citation xml:lang="en">Bonora E., Targher G., Alberiche M., Bonadonna R.C., Saggiani F., Zenere M.B., Monauni T., Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000 Jan; 23 (1): 57–63. doi: 10.2337/diacare.23.1.57</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Руяткина Л.А., Руяткин Д.С., Исхакова И.С. Возможности и варианты суррогатной оценки инсулинорезистентности. Ожирение и метаболизм. 2019; 16 (1): 27–32.</mixed-citation><mixed-citation xml:lang="en">Ruyatkina L.A., Ruyatkin D.S., Iskhakova I.S. Opportunities and options for surrogate assessment of insulin resistance. Obesity and Metabolism. 2019; 16 (1): 27–32 (in Russ.). doi: 10.14341/omet10082</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Huang R., Cheng Z., Jin X. et al. Usefulness of four surrogate indexes of insulin resistance in middle-aged population in Hefei, China. Ann. Med. 2022 Dec; 54 (1): 622–632. doi: 10.1080/07853890.2022.2039956</mixed-citation><mixed-citation xml:lang="en">Huang R., Cheng Z., Jin X. et al. Usefulness of four surrogate indexes of insulin resistance in middle-aged population in Hefei, China. Ann. Med. 2022 Dec; 54 (1): 622–632. doi: 10.1080/07853890.2022.2039956</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Guerrero-Romero F., Simental-Mendía L.E., González-Ortiz M., Martínez-Abundis E., Ramos-Zavala M.G., Hernández-González S.O., Jacques-Camarena O., Rodríguez-Morán M. The Product of Triglycerides and Glucose, a Simple Measure of Insulin Sensitivity. Comparison with the Euglycemic-Hyperinsulinemic Clamp. J. Clin. Endocrinol. Metab. 2010; 95 (7): 3347–3351. doi: 10.1210/jc.2010-0288</mixed-citation><mixed-citation xml:lang="en">Guerrero-Romero F., Simental-Mendía L.E., GonzálezOr tiz M., Martínez-Abundis E., Ramos-Zavala M.G., Hernández-González S.O., Jacques-Camarena O., Rodríguez-Morán M. The Product of Triglycerides and Glucose, a Simple Measure of Insulin Sensitivity. Comparison with the Euglycemic-Hyperinsulinemic Clamp. J. Clin. Endocrinol. Metab. 2010; 95 (7): 3347–3351. doi: 10.1210/jc.2010-0288</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Wang X., Feng C., Zhang B., Jiang G. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003–2018. Cardiovasc. Diabetol. 2024 Jan 6; 23 (1): 8. doi: 10.1186/s12933-023-02115-9</mixed-citation><mixed-citation xml:lang="en">Wang X., Feng C., Zhang B., Jiang G. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003–2018. Cardiovasc. Diabetol. 2024 Jan 6; 23 (1): 8. doi: 10.1186/s12933-023-02115-9</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Simental-Mendía L.E., Guerrero-Romero F. The correct formula for the triglycerides and glucose index. Eur. J. Pediatr. 2020 Jul; 179 (7): 1171. doi: 10.1007/s00431-020-03644-1</mixed-citation><mixed-citation xml:lang="en">Simental-Mendía L.E., Guerrero-Romero F. The correct formula for the triglycerides and glucose index. Eur. J. Pediatr. 2020 Jul; 179 (7): 1171. doi: 10.1007/s00431-020-03644-1</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Hwang Y., Son Y., Lee K. et al. Association between triglyceride glucose-body mass index and early-onset hypertension in South Korea: a nationwide cross-sectional study (2007–2023). Endocrine. 2026 May 4; 91 (1): 168. doi: 10.1007/s12020-026-04639-y</mixed-citation><mixed-citation xml:lang="en">Hwang Y., Son Y., Lee K. et al. Association between triglyceride glucose-body mass index and early-onset hypertension in South Korea: a nationwide cross-sectional study (2007–2023). Endocrine. 2026 May 4; 91 (1): 168. doi: 10.1007/s12020-026-04639-y</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Alberti K.G.M.M., Zimmet P., Shaw J. Metabolic syndrome – a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet. Med. 2006; 23 (5): 469–480.</mixed-citation><mixed-citation xml:lang="en">Alberti K.G.M.M., Zimmet P., Shaw J. Metabolic syndrome – a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet. Med. 2006; 23 (5): 469–480.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Sun Y., Ji H., Sun W., An X., Lian F. Triglyceride glucose (TyG) index: A promising biomarker for diagnosis and treatment of different diseases. Eur. J. Intern. Med. 2025 Jan; 131: 3–14. doi: 10.1016/j.ejim.2024.08.026 Epub 2024 Oct 29, PMID: 39510865</mixed-citation><mixed-citation xml:lang="en">Sun Y., Ji H., Sun W., An X., Lian F. Triglyceride glucose (TyG) index: A promising biomarker for diagnosis and treatment of different diseases. Eur. J. Intern. Med. 2025 Jan; 131: 3–14. doi: 10.1016/j.ejim.2024.08.026 Epub 2024 Oct 29, PMID: 39510865</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Yu L., Li Y., Ma R., Guo H., Zhang X., Yan Y., He J., Wang X., Niu Q., Guo S. Construction of a Personalized Insulin Resistance Risk Assessment Tool in Xinjiang Kazakhs Based on Lipid- and Obesity-Related Indices. Risk Manag. Healthc. Policy. 2022 Apr 13; 15: 631–641. doi: 10.2147/RMHP.S352401</mixed-citation><mixed-citation xml:lang="en">Yu L., Li Y., Ma R., Guo H., Zhang X., Yan Y., He J., Wang X., Niu Q., Guo S. Construction of a Personalized Insulin Resistance Risk Assessment Tool in Xinjiang Kazakhs Based on Lipid- and Obesity-Related Indices. Risk Manag. Healthc. Policy. 2022 Apr 13; 15: 631–641. doi: 10.2147/RMHP.S352401</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Selvi N.M.K., Nandhini S., Sakthivadivel V., Lokesh S., Srinivasan A.R., Sumathi S. Association of Triglyceride-Glucose Index (TyG index) with HbA1c and Insulin Resistance in Type 2 Diabetes Mellitus. Maedica (Bucur). 2021 Sep; 16 (3): 375–381. doi: 10.26574/maedica.2021.16.3.375</mixed-citation><mixed-citation xml:lang="en">Selvi N.M.K., Nandhini S., Sakthivadivel V., Lokesh S., Srinivasan A.R., Sumathi S. Association of Triglyceride-Glucose Index (TyG index) with HbA1c and Insulin Resistance in Type 2 Diabetes Mellitus. Maedica (Bucur). 2021 Sep; 16 (3): 375–381. doi: 10.26574/maedica.2021.16.3.375</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Yan H., Zhou Q., Wang Y., Tu Y., Zhao Y., Yu J., Chen K., Hu Y., Zhou Q., Zhang W., Zheng C. Associations between cardiometabolic indices and the risk of diabetic kidney disease in patients with type 2 diabetes. Cardiovasc. Diabetol. 2024 Apr 25; 23 (1): 142. doi: 10.1186/s12933-024-02228-9</mixed-citation><mixed-citation xml:lang="en">Yan H., Zhou Q., Wang Y., Tu Y., Zhao Y., Yu J., Chen K., Hu Y., Zhou Q., Zhang W., Zheng C. Associations between cardiometabolic indices and the risk of diabetic kidney disease in patients with type 2 diabetes. Cardiovasc. Diabetol. 2024 Apr 25; 23 (1): 142. doi: 10.1186/s12933-024-02228-9</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Tang Q., Guo X.G., Sun Q., Ma J. The pre-ablation triglyceride-glucose index predicts late recurrence of atrial fibrillation after radiofrequency ablation in non-diabetic adults. BMC Cardiovasc. Disord. 2022 May 14; 22 (1): 219. doi: 10.1186/s12872-022-02657-y</mixed-citation><mixed-citation xml:lang="en">Tang Q., Guo X.G., Sun Q., Ma J. The pre-ablation triglyceride-glucose index predicts late recurrence of atrial fibrillation after radiofrequency ablation in non-diabetic adults. BMC Cardiovasc. Disord. 2022 May 14; 22 (1): 219. doi: 10.1186/s12872-022-02657-y</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Xu X., Huang R., Lin Y., Guo Y., Xiong Z., Zhong X., Ye X., Li M., Zhuang X., Liao X. High triglyceride-glucose index in young adulthood is associated with incident cardiovascular disease and mortality in later life: insight from the CARDIA study. Cardiovasc. Diabetol. 2022 Aug 12; 21 (1): 155. doi: 10.1186/s12933-022-01593-7</mixed-citation><mixed-citation xml:lang="en">Xu X., Huang R., Lin Y., Guo Y., Xiong Z., Zhong X., Ye X., Li M., Zhuang X., Liao X. High triglyceride-glucose index in young adulthood is associated with incident cardiovascular disease and mortality in later life: insight from the CARDIA study. Cardiovasc. Diabetol. 2022 Aug 12; 21 (1): 155. doi: 10.1186/s12933-022-01593-7</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Hoddy K.K., Axelrod C.L., Mey J.T., Hari A., Beyl R.A., Blair J.B., Dantas W.S., Kirwan J.P. Insulin resistance persists despite a metabolically healthy obesity phenotype. Obesity (Silver Spring). 2022 Jan; 30 (1): 39–44. doi: 10.1002/oby.23312</mixed-citation><mixed-citation xml:lang="en">Hoddy K.K., Axelrod C.L., Mey J.T., Hari A., Beyl R.A., Blair J.B., Dantas W.S., Kirwan J.P. Insulin resistance persists despite a metabolically healthy obesity phenotype. Obesity (Silver Spring). 2022 Jan; 30 (1): 39–44. doi: 10.1002/oby.23312</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Weyman-Vela Y., Guerrero-Romero F., Simental-Mendía L.E. The triglycerides and glucose index is more strongly associated with metabolically healthy obesity phenotype than the lipid and obesity indices. J. Endocrinol. Invest. 2024 Apr; 47 (4): 865–871. doi: 10.1007/s40618-023-02201-5</mixed-citation><mixed-citation xml:lang="en">Weyman-Vela Y., Guerrero-Romero F., Simental-Mendía L.E. The triglycerides and glucose index is more strongly associated with metabolically healthy obesity phenotype than the lipid and obesity indices. J. Endocrinol. Invest. 2024 Apr; 47 (4): 865–871. doi: 10.1007/s40618-023-02201-5</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Bell J.A., Hamer M., Batty G.D., Singh-Manoux A., Sabia S., Kivimäki M. Incidence of Metabolic Risk Factors Among Healthy Obese Adults: 20-Year Follow-Up. J. Am. Coll. Cardiol. 2015 Aug 18; 66 (7): 871–873. doi: 10.1016/j.jacc.2015.06.014</mixed-citation><mixed-citation xml:lang="en">Bell J.A., Hamer M., Batty G.D., Singh-Manoux A., Sabia S., Kivimäki M. Incidence of Metabolic Risk Factors Among Healthy Obese Adults: 20-Year Follow-Up. J. Am. Coll. Cardiol. 2015 Aug 18; 66 (7): 871–873. doi: 10.1016/j.jacc.2015.06.014</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Zakerkish M., Hoseinian A., Alipour M., Payami S.P. The Association between Cardio-metabolic and hepatic indices and anthropometric measures with metabolically obesity phenotypes: a cross-sectional study from the Hoveyzeh Cohort Study. BMC Endocr. Disord. 2023 May 29; 23 (1): 122. doi: 10.1186/s12902-023-01372-9</mixed-citation><mixed-citation xml:lang="en">Zakerkish M., Hoseinian A., Alipour M., Payami S.P. The Association between Cardio-metabolic and hepatic indices and anthropometric measures with metabolically obesity phenotypes: a cross-sectional study from the Hoveyzeh Cohort Study. BMC Endocr. Disord. 2023 May 29; 23 (1): 122. doi: 10.1186/s12902-023-01372-9</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Li Y., Gui J., Liu H., Guo L.L., Li J., Lei Y., Li X., Sun L., Yang L., Yuan T., Wang C., Zhang D., Wei H., Li J., Liu M., Hua Y., Zhang L. Predicting metabolic syndrome by obesity- and lipid-related indices in mid-aged and elderly Chinese: a population-based cross-sectional study. Front. Endocrinol (Lausanne). 2023 Jul 28; 14: 1201132. doi: 10.3389/fendo.2023.1201132</mixed-citation><mixed-citation xml:lang="en">Li Y., Gui J., Liu H., Guo L.L., Li J., Lei Y., Li X., Sun L., Yang L., Yuan T., Wang C., Zhang D., Wei H., Li J., Liu M., Hua Y., Zhang L. Predicting metabolic syndrome by obesity- and lipid-related indices in mid-aged and elderly Chinese: a population-based cross-sectional study. Front. Endocrinol (Lausanne). 2023 Jul 28; 14: 1201132. doi: 10.3389/fendo.2023.1201132</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
